NCT06743997

A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

A Randomized, Open Label, Single Subcutaneous Dose, 2x2 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: LG Chem · Industry
• Sex: All
• Age: 19 Years – 40 Years
• Healthy volunteers: Accepted

Summary

A randomized, Open Label, Single Subcutaneous Dose, 2x2 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Test Drug (Eutropin Catridge, 48IU/Cartridge)	Liqid somatropin
DRUG	Reference Drug (Eutropin, 4 IU/vial)	Lyophilized somatropin

Timeline

• Start date: 2025-01-13
• Primary completion: 2025-04-15
• Completion: 2025-04-15
• First posted: 2024-12-20
• Last updated: 2025-04-17

Locations

1 site across 1 country: South Korea